Alpine Immune Sciences, Inc.
ALPNDelisted May 20, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001626199
Alpine Immune Sciences, Inc. was delisted on May 20, 2024; its insiders filed their last Form 4 on May 20, 2024; 180 institutions reported holding it in 13F filings for Q1 2024, worth $2.56B in total; no superinvestor held it.
13F holders, Q2 2022
Institutional positions in Alpine Immune Sciences, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 58
- +3 vs. Q1 2022
- Shares held
- 24.0M
- −713.6K (−2.9%) vs. Q1 2022
- Total value
- $204.4M
- −$17.4M (−7.9%) vs. Q1 2022
- New holders
- 9
- 22 more added
- Sold out
- 6
- 17 more reduced
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ALPN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 180 | $2.56B |
| Q4 2023 | 133 | $1.12B |
| Q3 2023 | 88 | $525.8M |
| Q2 2023 | 77 | $449.3M |
| Q1 2023 | 61 | $319.4M |
| Q4 2022 | 64 | $300.8M |
| Q3 2022 | 70 | $284.0M |
| Q2 2022 | 58 | $204.4M |
| Q1 2022 | 56 | $221.8M |
| Q4 2021 | 53 | $257.1M |
| Q3 2021 | 44 | $163.5M |
| Q2 2021 | 47 | $118.5M |
| Q1 2021 | 48 | $145.0M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Alpine Immune Sciences, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Credit Suisse AG | 15 | $0 | 0.00% | +15 | New |
| Royal Bank of Canada | 88 | $1.00K | 0.00% | −625−87.7% | Reduced |
| FMR LLC | 134 | $1.00K | 0.00% | −132−49.6% | Reduced |
| Daiwa Securities Group Inc. | 85 | $1.00K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 290 | $2.00K | 0.00% | −5,413−94.9% | Reduced |
| Simplex Trading, LLC | 396 | $3.00K | 0.00% | +396 | New |
| Barclays PLC | 783 | $7.00K | 0.00% | −1,103−58.5% | Reduced |
| Ameritas Investment Partners, Inc. | 911 | $7.00K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 1,200 | $10.0K | 0.00% | −1,169−49.3% | Reduced |
| Legal & General Group Plc | 1,442 | $12.0K | 0.00% | +215+17.5% | Added |
| Citigroup Inc | 1,597 | $14.0K | 0.00% | +554+53.1% | Added |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 2,045 | $17.0K | 0.00% | −212−9.4% | Reduced |
| Amalgamated Bank | 2,014 | $17.0K | 0.00% | +123+6.5% | Added |
| BNP Paribas Arbitrage, SA | 3,482 | $29.6K | 0.00% | −295−7.8% | Reduced |
| Lazard Asset Management LLC | 4,617 | $39.0K | 0.00% | +4,617 | New |
| STRS Ohio | 5,500 | $46.0K | 0.00% | 00.0% | Unchanged |
| New York State Common Retirement Fund | 5,397 | $46.0K | 0.00% | 00.0% | Unchanged |
| California State Teachers Retirement System | 6,679 | $57.0K | 0.00% | +1,712+34.5% | Added |
| American International Group, Inc. | 7,310 | $62.0K | 0.00% | +1,543+26.8% | Added |
| Deutsche Bank AG | 9,089 | $77.0K | 0.00% | +2,789+44.3% | Added |
| JPMorgan Chase & Co | 9,669 | $82.0K | 0.00% | +722+8.1% | Added |
| Bank of America Corp | 9,875 | $85.0K | 0.00% | −5,567−36.1% | Reduced |
| Hikari Power Ltd | 12,445 | $106.0K | 0.01% | 00.0% | Unchanged |
| Morgan Stanley | 13,199 | $112.0K | 0.00% | +3,922+42.3% | Added |
| Susquehanna International Group, LLP | 14,121 | $120.0K | 0.00% | +1,700+13.7% | Added |
| Nuveen Asset Management, LLC | 18,446 | $157.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 20,030 | $170.0K | 0.00% | −27,678−58.0% | Reduced |
| Rhumbline Advisers | 20,404 | $174.0K | 0.00% | +20,404 | New |
| Tower Research Capital LLC (TRC) | 21,209 | $180.0K | 0.00% | +19,205+958.3% | Added |
| Western Wealth Management, LLC | 25,120 | $214.0K | 0.01% | +25,120 | New |
| Marshall Wace, LLP | 35,930 | $305.0K | 0.00% | +35,930 | New |
| Charles Schwab Investment Management Inc | 39,823 | $339.0K | 0.00% | +7,406+22.8% | Added |
| Goldman Sachs Group Inc | 42,916 | $365.0K | 0.00% | +20,066+87.8% | Added |
| Alberta Investment Management Corp | 45,906 | $391.0K | 0.00% | +45,906 | New |
| Connor, Clark & Lunn Investment Management Ltd. | 50,189 | $427.0K | 0.00% | +21,873+77.2% | Added |
| Western Standard LLC | 50,328 | $428.0K | 0.32% | +50,328 | New |
| Dimensional Fund Advisors LP | 51,370 | $437.0K | 0.00% | −1,694−3.2% | Reduced |
| Bank of New York Mellon Corp | 58,554 | $499.0K | 0.00% | +9,399+19.1% | Added |
| Bridgeway Capital Management, LLC | 95,611 | $814.0K | 0.02% | −50,000−34.3% | Reduced |
| Two Sigma Advisers, LP | 101,575 | $864.0K | 0.00% | −12,600−11.0% | Reduced |
| Northern Trust Corp | 125,774 | $1.07M | 0.00% | +24,066+23.7% | Added |
| Allspring Global Investments Holdings, LLC | 136,797 | $1.16M | 0.00% | +119,935+711.3% | Added |
| Geode Capital Management, LLC | 247,992 | $2.11M | 0.00% | +32,836+15.3% | Added |
| State Street Corp | 268,082 | $2.28M | 0.00% | +47,461+21.5% | Added |
| Renaissance Technologies LLC | 397,394 | $3.38M | 0.00% | +11,300+2.9% | Added |
| Great Point Partners LLC | 538,819 | $4.58M | 1.18% | +538,819 | New |
| TCG Crossover Management, LLC | 578,260 | $4.92M | 2.09% | −455,962−44.1% | Reduced |
| Artal Group S.A. | 593,030 | $5.05M | 0.28% | 00.0% | Unchanged |
| Vanguard Group Inc | 629,773 | $5.36M | 0.00% | −77,825−11.0% | Reduced |
| Paradigm Biocapital Advisors LP | 826,779 | $7.04M | 1.40% | +490,550+145.9% | Added |
| BlackRock Inc. | 878,368 | $7.48M | 0.00% | +155,230+21.5% | Added |
| Avidity Partners Management LP | 998,565 | $8.50M | 0.20% | −208,435−17.3% | Reduced |
| BVF Inc | 1,275,240 | $10.9M | 0.52% | −314,255−19.8% | Reduced |
| Lynx1 Capital Management LP | 1,926,869 | $16.4M | 13.97% | +442,176+29.8% | Added |
| Omega Fund Management, LLC | 2,029,580 | $17.3M | 5.51% | 00.0% | Unchanged |
| Frazier Life Sciences Management, L.P. | 2,985,757 | $25.4M | 2.40% | −1,200,000−28.7% | Reduced |
| OrbiMed Advisors LLC | 4,081,592 | $34.7M | 0.67% | 00.0% | Unchanged |
| Decheng Capital Management III (Cayman), LLC | 4,708,288 | $40.1M | 15.19% | 00.0% | Unchanged |
| Jacobs Levy Equity Management, Inc | 0 | $0 | 0.00% | −138,279−100.0% | Sold out |
| Tiger Management L.L.C. | 0 | $0 | 0.00% | −137,728−100.0% | Sold out |
| Ensign Peak Advisors, Inc | 0 | $0 | 0.00% | −110,017−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −41,746−100.0% | Sold out |
| Alps Advisors Inc | 0 | $0 | 0.00% | −30,030−100.0% | Sold out |
| Kingsbury Capital Investment Advisors LLC | 0 | $0 | 0.00% | −29,153−100.0% | Sold out |
| Amalgamated Financial Corp. | – | – | – | – | Not filed |